Cera™ VSD Occluder Post Market Clinical Follow-up

CompletedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

October 13, 2023

Primary Completion Date

March 4, 2025

Study Completion Date

March 4, 2025

Conditions
Ventricular Septal Defect
Interventions
DEVICE

Cera™ VSD occluder implantation

To collect data from patients who have implanted with the device before 2022.

Trial Locations (8)

Unknown

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Kaohsiung Veterans General Hospital, Kaohsiung City

Taichung Veterans General Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

Taipei Mackay Memorial Hospital, Taipei

Taipei Veterans General Hospital, Taipei

Linkou Chang-Gung Memorial Hospita, Taoyuan District

All Listed Sponsors
lead

Cardiac Children's Foundation Taiwan

OTHER

NCT05939713 - Cera™ VSD Occluder Post Market Clinical Follow-up | Biotech Hunter | Biotech Hunter